Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

How can we treat mitochondrial encephalomyopathies? Approaches to therapy.

Horvath R, Gorman G, Chinnery PF.

Neurotherapeutics. 2008 Oct;5(4):558-68. doi: 10.1016/j.nurt.2008.07.002. Review.

2.

Current options in the treatment of mitochondrial diseases.

Scarpelli M, Cotelli MS, Mancuso M, Tomelleri G, Tonin P, Baronchelli C, Vielmi V, Gregorelli V, Todeschini A, Padovani A, Filosto M.

Recent Pat CNS Drug Discov. 2010 Nov;5(3):203-9. Review.

PMID:
20722626
3.

The therapy of respiratory chain encephalomyopathy: a critical review of the past and current perspective.

Walker UA, Byrne E.

Acta Neurol Scand. 1995 Oct;92(4):273-80. Review.

PMID:
8848932
4.

Mitochondrial encephalomyopathies: therapeutic approaches.

DiMauro S, Hirano M, Schon EA.

Neurol Sci. 2000;21(5 Suppl):S901-8. Review.

PMID:
11382187
5.

Mitochondrial encephalomyopathies: therapeutic approach.

Dimauro S, Mancuso M, Naini A.

Ann N Y Acad Sci. 2004 Apr;1011:232-45.

PMID:
15126300
6.

Diagnosis of the mitochondrial encephalomyopathies.

Shanske S, DiMauro S.

Curr Opin Rheumatol. 1997 Nov;9(6):496-503. Review.

PMID:
9375278
7.

[Diagnosis and therapy of mitochondriopathies].

Sperl W.

Wien Klin Wochenschr. 1997 Feb 14;109(3):93-9. Review. German.

PMID:
9139466
8.

Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options.

El-Hattab AW, Scaglia F.

Neurotherapeutics. 2013 Apr;10(2):186-98. doi: 10.1007/s13311-013-0177-6. Review.

9.

[Mitochondrial encephalopathy due to complex I deficiency. Brain tissue biopsy findings and clinical course following pharmacological].

Jiménez-Caballero PE, Mollejo-Villanueva M, Alvarez-Tejerina A.

Rev Neurol. 2008 Jul 1-15;47(1):27-30. Spanish.

10.

Mitochondrial biogenesis: pharmacological approaches.

Valero T.

Curr Pharm Des. 2014;20(35):5507-9.

PMID:
24606795
11.

Metabolic changes in patients with mitochondrial myopathies and effects of coenzyme Q10 therapy.

Chan A, Reichmann H, Kögel A, Beck A, Gold R.

J Neurol. 1998 Oct;245(10):681-5.

PMID:
9776469
12.

Mitochondrial diseases: therapeutic approaches.

DiMauro S, Mancuso M.

Biosci Rep. 2007 Jun;27(1-3):125-37. Review.

PMID:
17486439
13.

Treatment of mitochondrial cytopathies.

Gold DR, Cohen BH.

Semin Neurol. 2001 Sep;21(3):309-25. Review.

PMID:
11641821
14.

Coenzyme Q10.

Bonakdar RA, Guarneri E.

Am Fam Physician. 2005 Sep 15;72(6):1065-70. Review.

15.

Treatment for mitochondrial disorders.

Pfeffer G, Majamaa K, Turnbull DM, Thorburn D, Chinnery PF.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD004426. doi: 10.1002/14651858.CD004426.pub3. Review.

PMID:
22513923
16.

Mitochondrial encephalomyopathies.

Oldfors A, Tulinius M.

J Neuropathol Exp Neurol. 2003 Mar;62(3):217-27. Review.

17.

Gastrointestinal and hepatic manifestations of mitochondrial disorders.

Rahman S.

J Inherit Metab Dis. 2013 Jul;36(4):659-73. doi: 10.1007/s10545-013-9614-2. Review.

PMID:
23674168
18.

The clinical maze of mitochondrial neurology.

DiMauro S, Schon EA, Carelli V, Hirano M.

Nat Rev Neurol. 2013 Aug;9(8):429-44. doi: 10.1038/nrneurol.2013.126. Review.

19.

Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency.

Rötig A, Appelkvist EL, Geromel V, Chretien D, Kadhom N, Edery P, Lebideau M, Dallner G, Munnich A, Ernster L, Rustin P.

Lancet. 2000 Jul 29;356(9227):391-5.

PMID:
10972372
20.

Gene therapy using a liver-targeted AAV vector restores nucleoside and nucleotide homeostasis in a murine model of MNGIE.

Torres-Torronteras J, Viscomi C, Cabrera-Pérez R, Cámara Y, Di Meo I, Barquinero J, Auricchio A, Pizzorno G, Hirano M, Zeviani M, Martí R.

Mol Ther. 2014 May;22(5):901-7. doi: 10.1038/mt.2014.6.

Items per page

Supplemental Content

Support Center